I was excited to find that my university has a Read & Publish agreement with The Company of Biologists. This meant that I could immediately publish our study of the role of Collagen-6 in the cancer microenvironment as an Open Access article when it was accepted in Journal of Cell Science. This kind of arrangement means that authors can make their work more accessible to everyone and reach a wide audience.
The Company of Biologists was one of the first publishers IReL signed a Read & Publish agreement with. We have been impressed with how they have been a leading example of a small, not-for-profit publisher offering their Read & Publish to libraries and consortia globally, and how they have been active in sharing emerging best practice in OA publishing with the scholarly communications community
It is fantastic to have my final chapter of my PhD published in Journal of Experimental Biology. Additionally, this is my second manuscript to be published for no cost with immediate Open Access as a result of the Read & Publish agreement between the University of Akron and The Company of Biologists. The entire publishing process went smoothly, and this article was also chosen to be featured in their 100 years of research ECR spotlight.
As an early career scientist, it can’t be overstated how important it is to publish Open Access to increase the visibility of your work.
I am really impressed with how streamlined publishing in the Journal of Experimental Biology has been, and I am truly grateful for their Read & Publish agreement with the University of California Libraries that allowed me to publish my thesis research with immediate Open Access so anyone can read it.
Having a Read & Publish agreement with The Company of Biologists, commencing in 2022, is an important continuation of CAUL’s progression to providing broader Open Access arrangements via consortium agreements. The agreement is useful not only for the access it gives to content across the biological sciences used by CAUL members, but also the ability to publish OA in these subject areas which will be highly valued for locally produced research. Agreements with organisations such as The Company of Biologists also confirm CAUL’s commitment to work with publishers of all sizes.
Open Access agreements such as Read & Publish are a step towards making scientific knowledge freely accessible to everyone, which is crucial for the advancement of research and understanding. The ability to immediately publish articles Open Access through the Read & Publish agreement between The Company of Biologists and University College London helped me share our findings and contributions with a wider audience, enabling greater collaboration and dissemination of knowledge. I am grateful for this agreement and the smooth publishing experience with Development.
The Company of Biologists was one of the first publishers MALMAD signed a Read & Publish agreement with. We are now very pleased to renew the agreement, covering the costs for researchers at seven institutions in Israel to publish an unlimited number of Open Access articles in all three of The Company’s hybrid journals, whilst also giving them reading access. Our continued cooperation is an important step in the transition to Open Access.
We were surprised and delighted to learn that our most recent Development paper could be published as an immediate Open Access article for free, thanks to a Read & Publish agreement with Johns Hopkins. The publishing experience was great – we’ll be back again. We truly value this 98 year-old non-profit publisher that is run by scientists, for scientists. Thanks to The Company of Biologists!
We are very pleased with the new Read & Publish agreement between The Company of Biologists and the Bibsam Consortium, covering costs for Swedish researchers at participating institutions to publish an unlimited number of Open Access articles in all five of The Company of Biologists’ journals, whilst also giving them read access. To sign transformative agreements with small not-for-profit publishers is an important step in line with our action plan to advance Open Science.
We’re delighted to offer this agreement. Not only does this transitional agreement support the UK in the transition to Open Access it will help provide the latest biological research for use and reuse at no charge by early-career biologists and cutting-edge researchers alike. This builds on the sector’s success in making over 50% of UK research Open Access and will amplify the impact and reach of research.
Visit our journal websites
